Humanitarian needs are escalating globally, with around 300 million people requiring assistance—over half in Africa. These ...

The Gaza Strip, home to more than 2 million people within 365 km², has long faced structural vulnerability in healthcare.

Five years after the start of the COVID-19 pandemic, pushback against global health initiatives is common amidst declining ...

Introduction Over 46 million people are living with rheumatic heart disease (RHD) globally, resulting in 380 000 premature ...

Background Although socioeconomic inequalities in infant mortality are well-documented globally, there is limited evidence ...

It is well established that social determinants influence people’s health and well-being. Yet, limited attention is given to ...

As we mark 5 years since the emergence of the COVID-19 pandemic, the world continues to face numerous epidemics of emerging and re-emerging diseases, including mpox, cholera, avian influenza, ...

Four decades of war and armed conflict have created a complex and prolonged humanitarian crisis in Afghanistan. The country, with a population of approximately 41 million, is grappling with rapid ...

Clinical research is sine qua non for understanding and solving public health challenges.1 Clinical trials are central to advancing scientific knowledge and can have an impact on many areas (but not ...

Over 10 million infants under 6 months of age worldwide are at risk of poor growth and development (henceforth ‘infants u6m’). 1 Risks include short-term mortality and non-communicable disease in ...

The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...